US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist
  • 26.895
  • -1.400-4.95%
Trading Dec 3 10:34 ET
2.23BMarket Cap-17022P/E (TTM)

Beam Therapeutics Key Stats

Beam Therapeutics Q3 2024 Earnings Date

Currency:USDNov 5, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
14.13M
14.27M
+137.03K
Beat Est.
-17.80%
-17.01%
+0.97%
EPS
-1.15
-1.17
-0.02
Miss Est.
+6.12%
+4.10%
-2.17%
Buy

Nov 30, 2024

Beam Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.200M--
--2024/Q4-- / 15.122M--
Nov 5, 20242024/Q314.269M / 14.132M--
--2024/Q211.772M / 13.047M--
--2024/Q17.410M / 14.664M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.200M--
--2024/Q4-- / 15.122M--
Nov 5, 20242024/Q314.269M / 14.132M--
--2024/Q211.772M / 13.047M--
--2024/Q17.410M / 14.664M--

Unlock Free Earnings Estimates

Beam Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data